Seok Ki Choi

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface
    Seok Ki Choi
    Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    ACS Nano 7:214-28. 2013
  2. ncbi Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate
    Seok Ki Choi
    Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109, USA
    Photochem Photobiol Sci 11:653-60. 2012
  3. ncbi A photochemical approach for controlled drug release in targeted drug delivery
    Seok Ki Choi
    Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109, USA
    Bioorg Med Chem 20:1281-90. 2012
  4. ncbi Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate
    Seok Ki Choi
    Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Medical School, Ann Arbor, MI 48109, USA
    Chem Commun (Camb) 46:2632-4. 2010
  5. ncbi Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic
    Thommey P Thomas
    Michigan Nanotechnology Institute for Medicine and Biological Sciences, Ann Arbor, Michigan 48109, United States
    Mol Pharm 9:2669-76. 2012
  6. ncbi Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting
    Ming Hsin Li
    Michigan Nanotechnology Institute for Medicine and Biological Sciences, and Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA
    Eur J Med Chem 47:560-72. 2012
  7. ncbi Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery
    Thommey P Thomas
    Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, Division of Allergy, University of Michigan, Ann Arbor, MI 48109, USA
    Bioorg Med Chem Lett 20:5191-4. 2010
  8. ncbi Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action
    Erika N Cline
    Cellular and Molecular Biology Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA
    Biomacromolecules 14:654-64. 2013

Collaborators

  • Mark M Banaszak Holl
  • Andrzej Myc
  • Thommey P Thomas
  • James R Baker
  • Ming Hsin Li
  • Alina Kotlyar
  • Erika N Cline
  • Nils G Walter
  • Ronald G Larson
  • Neha Kaul
  • Edgar Meyhofer
  • Jeffrey F Herbstman
  • Georgios Skiniotis
  • Hong Zong
  • Ankur Desai
  • Baohua Huang
  • Justin E Silpe
  • Jeremy Gam
  • Kyung Hoon Lee
  • Melvin Joice
  • Mark M Banaszak Holl
  • Ankur M Desai

Detail Information

Publications8

  1. ncbi Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface
    Seok Ki Choi
    Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    ACS Nano 7:214-28. 2013
    ....
  2. ncbi Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate
    Seok Ki Choi
    Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109, USA
    Photochem Photobiol Sci 11:653-60. 2012
    ....
  3. ncbi A photochemical approach for controlled drug release in targeted drug delivery
    Seok Ki Choi
    Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109, USA
    Bioorg Med Chem 20:1281-90. 2012
    ..The rate of the drug release varies in response to multiple control parameters, including linker design, light wavelength, exposure time, and the pH of the medium where the drug release occurs...
  4. ncbi Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate
    Seok Ki Choi
    Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Medical School, Ann Arbor, MI 48109, USA
    Chem Commun (Camb) 46:2632-4. 2010
    ..We report the synthesis and in vitro evaluation of folate receptor-targeted nanoconjugate that releases its therapeutic payload via a photochemical mechanism...
  5. ncbi Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic
    Thommey P Thomas
    Michigan Nanotechnology Institute for Medicine and Biological Sciences, Ann Arbor, Michigan 48109, United States
    Mol Pharm 9:2669-76. 2012
    ..The newly synthesized G5-MTX(n) conjugate may serve as a FR-targeted chemotherapeutic with potential for cancer therapy...
  6. ncbi Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting
    Ming Hsin Li
    Michigan Nanotechnology Institute for Medicine and Biological Sciences, and Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA
    Eur J Med Chem 47:560-72. 2012
    ....
  7. ncbi Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery
    Thommey P Thomas
    Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, Division of Allergy, University of Michigan, Ann Arbor, MI 48109, USA
    Bioorg Med Chem Lett 20:5191-4. 2010
    ....
  8. ncbi Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action
    Erika N Cline
    Cellular and Molecular Biology Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA
    Biomacromolecules 14:654-64. 2013
    ..Our results provide mechanistic insights into the cytotoxicity of paclitaxel-conjugated PAMAM dendrimers and uncover unexpected risks of using such conjugates therapeutically...